Types of hepatitis
HEPATITIS - symptoms
How To Diagnose Hepatitis?
Treatment
Main Prevention Measures for Hepatitis B and C
Hepatitis in Pregnant Women
Oral Manifestations of Hepatitis
Management of patients with hepatitis B and C infection in dental office
It include the definition , signs and symptoms, types, diagnosis, medical management, Nursing management, preventive measures, complication, Post exposure prophylaxis of Hepatitis.
It include the definition , signs and symptoms, types, diagnosis, medical management, Nursing management, preventive measures, complication, Post exposure prophylaxis of Hepatitis.
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
#Hepatitis#definition#virus#types #hepatitis A#hepatitis B#hepatitis c #hepatitis D#hepatitis E#signs #symptoms#liver#effected by hepatitis#picture presentation of each type#treatment#vaccines#prevention from disease
#world hepatitis day
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
#Hepatitis#definition#virus#types #hepatitis A#hepatitis B#hepatitis c #hepatitis D#hepatitis E#signs #symptoms#liver#effected by hepatitis#picture presentation of each type#treatment#vaccines#prevention from disease
#world hepatitis day
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
Hepatitis B and C infection and it's clinical implication in Dental practice, how to management patients of hepatitis and what clinical features patients with hepatitis show in oral cavity.
Oral hiv/certified fixed orthodontic courses by Indian dental academyIndian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
AIDS is a lethal viral infection caused by human immunodeficiency virus (HIV) and is characterized by severe depletion of T4 lymphocytes with associated opportunistic infections.
Oral and perioral lesions are common in patients infected with human immune deficiency virus (HIV), are often the presenting feature, and may predict deterioration in general health and a poor prognosis.
Due to multiple oral conditions and periodontal involvement, periodontists are in a unique position to recognize possible HIV infection in its early stage and to be involved in the oral care of these patients.
This is an informative, illustrated presentation about the causes, symptoms, treatment and prevention of HIV AIDS. Gives relevant data, facts and statistics about the disease updated to the most recent 2010 data.
This file contains the informational about hepatitis. templates used in this are self made. This is an educational and medical oriented ppt made for the school project. dark vibrant color combination add a glimpse of flavour in it.
Comprehending Hepatitis B: Origins, Signs, Preventive measures, and Managementkkaif2906
Hepatitis B is a viral infection that primarily affects the liver. It is caused by the Hepatitis B virus (HBV), which can be transmitted through contact with infected blood, semen, or other bodily fluids. Hepatitis B can manifest as an acute or chronic condition, with symptoms including fatigue, fever, nausea, abdominal pain, and jaundice. Chronic Hepatitis B can lead to serious liver complications such as cirrhosis and liver cancer. Prevention strategies include vaccination, practicing safe sex, avoiding needle sharing, and screening pregnant women for HBV. While there is no cure for Hepatitis B, antiviral medications can help manage the infection and reduce the risk of complications. Regular monitoring is essential for individuals with chronic Hepatitis B to assess disease progression and determine the need for treatment adjustments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
4. Global burden of hepatitis
• About 1 million people die each year from
causes related to viral hepatitis.
• Acute hepatitis B and C, cancer and cirrhosis
of the liver accounts for about 2.7% of all
deaths.
5. Adapted from Lauer and Walker, NEJM 2001
Healthy
Liver
Acute
Infection
Chronic
Infection
20%
Clear the
Virus
80% Virus
Continues
to Damage
Liver
Only 20% will
show symptoms
initially !
7. HEPATITIS - symptoms
• ACUTE:
• Malaise
• Muscle and joint ache
• Fever
• Nausea or vomiting
• Loss of apetite
• Abdominal pain
• CHRONIC:
• Malaise, tiredness,
weakness
• Weight loss
• Peripheral oedema
• Ascites
8. • A few may have specific liver related
symptoms initially:
– Pale stool
– Jaundice (yellowing of the skin or eyes)
9. Hepatitis A
• More common in children
• It causes prolonged illness for up to 6 months,
but usually only causes mild illness.
• It does not cause chronic liver disease.
• In milder cases, symptoms may be similar to a
stomach virus (with vomiting and diarrhea).
10. The CDC now recommends the vaccine for
hepatitis A to children at age 1 with special
recommendation for the following children:
Blood clotting disorder, such as hemophilia
Child care centers that have had outbreaks of
hepatitis A
Chronic liver disease
The vaccine is not recommended for children
younger than age 12 months.
11. How To Diagnose Hepatitis?
Several laboratory tests are done to
diagnose and monitor the hepatitis, which
includes:
• Abdominal ultrasound
• Autoimmune blood markers
• Hepatitis virus serologies
• Liver function tests
• Liver biopsy
12. Hepatitis virus serologies
Series of blood tests used to detect current or past infection by
hepatitis A, hepatitis B, or hepatitis C.
NEGATIVE RESULTS NORMAL
POSITIVE RESULTS HEPATITIS INFECTION
13. Hepatitis A test results:
IgM anti-hepatitis A virus (HAV) antibodies – recent infection
Total (IgM and IgG) antibodies to hepatitis A – past infection
Hepatitis B test results:
HBsAg - 1-6 months after exposure
HBeAg - 1-3 months after acute illness, high infectivity
anti-HBc - past infection
anti-HBs - implies vaccination
Antibodies to hepatitis C
Can usually be detected 4 - 10 weeks after the infection occurs. Other
types of tests may be done to decide on treatment and monitor the
hepatitis C infection.
14. Liver Function Test:
The test measures the levels of certain enzymes and proteins in your blood.
Hepatitis A : AST and ALT increases.
Hepatitis B : AST and ALT increases.
15. Treatment
Hepatitis A:
No specific treatment, dietary food and
long rest recommended and avoid alcohol.
Hepatitis B :
• Treatment to prevent hepatitis B infection after exposure
Hepatitis B immune globulin injection within 24 hours of coming in contact
with the virus may help protect you from developing hepatitis B.
• Treatment for acute hepatitis B infection
Hepatitis B infection is acute — reduce any signs and symptoms.
• Treatment for chronic hepatitis B infection
1. Antiviral medications : Lamivudine, Adefovir, Famciclovir.
2. Liver transplant: If the liver is severely damaged, a liver transplant may be
an option. Survival with transplant is now 70-80%
16. Hepatitis C:
Treated with a combination of pegylated
interferon and ribovarin.
Patients with chronic hepatitis C who are
receiving standard HCV treatment may benefit
significantly by taking vitamin B12
supplements.
17. Main Prevention Measures for
Hepatitis B and C
• Promote vaccination against hepatitis B.
• Avoid sharing injecting equipments such as needles and syringes
and ensure adequately sterilized medical equipment use.
• Promote hepatitis B and C testing and counselling services.
• Raise awareness of the diseases and their transmission mode.
• Individuals up to 18 years of age and adult participating at risk of
infection should be vaccinated. Three injections over a six to 12
month period are required to provide full protection.
18. Dispelling Myths
• Hepatitis C is not spread by:
Casual contact
Hugging/kissing
Sharing eating utensils and drinking glasses
Sneezing/coughing
Shaking hands
Sitting on a toilet seat
19. Hepatitis in Pregnant Women
• Hepatitis in pregnant women usually does not increase the risk of birth
defects or other pregnancy problems, and infection of the unborn baby is
rare.
• However, hepatitis E can be fatal to a pregnant woman during her third
trimester, and if the mother has hepatitis B, the baby is likely to contract
the disease at birth.
• If the pregnant mother is infected with hepatitis B then the baby will be
given immune globulin shots and a hepatitis vaccination.
• In addition, it is recommended that a mother with active HBV receive
treatment with an antiviral medication during the third trimester of
pregnancy.
20. Oral Manifestations of Hepatitis
• Morbidity associated with hepatitis C virus (HCV) infection can involve a
variety of extrahepatic conditions, such lichen planus (LP) and Sjögren-like
sialadenitis.
21. Management of patients with hepatitis B
and C infection in dental office
• Patients with hepatitis receiving dental treatment should be handled with
precautions as there is risk of Cross infection.
• Use of universal protective measures is recommended.
• In case of accidental perforation, careful washing of the wound ( without
rubbing, as this may inoculate the virus into deeper tissues) for several
minutes with soap and water, or using a disinfectant of established
efficacy against the virus (iodine solutions or chlorine formulations).
• If exposure through some mucosal membrane has occurred, abundant
irrigation with tap water, sterile saline solution or sterile water is advised,
for several minutes.
22. Therefore a detailed clinical history should be taken before
dental treatment and a thorough oral examination in order to
identify patients with possible risks.
Interconsultation with the patient physician or specialist is
advisable in order to establish a safe and adequate treatment
plan.
Acute-phase viral hepatitis only emergency treatment
Chronic hepatitis determine the possible existence of associated
disorders in order to prevent their direct complications and
problems
23.
24. References
• Jump up to:a b Ryan KJ, Ray CG (editors), ed. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 551–
2. ISBN 0838585299.
• ^ Jump up to:a b Gravitz L. (2011). "A smouldering public-health crisis". Nature 474 (7350): S2-
4.doi:10.1038/474S2a. PMID 21666731.
• ^ Jump up to:a b c d "Hepatitis C". World Health Organization (WHO). June 2011. Retrieved 2011-07-13.
• ^ Jump up to:a b c Mohd Hanafiah, K; Groeger, J; Flaxman, AD; Wiersma, ST (2013 Apr). "Global epidemiology of
hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.". Hepatology
(Baltimore, Md.) 57 (4): 1333–42.PMID 23172780.
• Jump up^ Houghton M (November 2009). "The long and winding road leading to the identification of the hepatitis
C virus". Journal of Hepatology 51 (5): 939–48.doi:10.1016/j.jhep.2009.08.004. PMID 19781804.
• Jump up^ Shors, Teri (2011-11-08). Understanding viruses (2nd ed.). Burlington, MA: Jones & Bartlett Learning.
p. 535. ISBN 9780763785536.
• ^ Jump up to:a b c d e f g h i j k l Rosen, HR (2011-06-23). "Clinical practice. Chronic hepatitis C infection". The New
England Journal of Medicine 364 (25): 2429–38.doi:10.1056/NEJMcp1006613. PMID 21696309.
• Jump up^ Maheshwari, A; Ray S; Thuluvath PJ (2008-07-26). "Acute hepatitis C". Lancet 372(9635): 321–
32. doi:10.1016/S0140-6736(08)61116-2. PMID 18657711.
• ^ Jump up to:a b c d e f g h i j k l m n o p q r s t u Wilkins, T; Malcolm JK; Raina D; Schade RR (2010-06-01). "Hepatitis C:
diagnosis and treatment". American family physician 81 (11): 1351–7. PMID 20521755.
• Jump up^ Bailey, Caitlin (Nov 2010). "Hepatic Failure: An Evidence-Based Approach In The Emergency
Department". Emergency Medicine Practice 12 (4).
• ^ Jump up to:a b c d e Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. Springer Verlag.
2011. p. 4. ISBN 9781461411918.
• ^ Jump up to:a b c d Nelson, PK; Mathers BM, Cowie B, H